Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 9, 2001, Pages 1034-1057

  Mawlawi, Osama ^a,b   Martinez, Diana ^a,b   Slifstein, Mark ^a,b   Broft, Allegra ^b   Chatterjee, Rano ^b   Hwang, Dah Ren ^a,b   Huang, Yiyun ^a,b   Simpson, Norman ^a   Ngo, Kim ^b   Van Heertum, Ronald ^a   Laruelle, Marc ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

D2 receptor; Dopamine; Nucleus accumbens; Partial volume effects; Positron emission tomography; Ventral striatum; 11C Raclopride

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ACCURACY; ADULT; ARTICLE; BINDING AFFINITY; BRAIN SIZE; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGING; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; REPRODUCIBILITY;

EID: 0034840454     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200109000-00002     Document Type: Article

References (67)

1. SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: Kinetic and equilibrium paradigms
2. Reliable quantification of both striatal and extrastriatal D2 receptors in humans with [18F]fallypride
3. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: Validation and reproducibility
4. A block spin construction of ondelettes 1. Lemarie functions
5. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
6. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
7. Performance evaluation of a whole-body PET scanner using the NEMA protocol
8. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites
9. Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion
10. Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects
11. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain
12. Mechanisms of action of atypical antipsychotic drugs. Implication for novel therapeutic strategies for schizophrenia
13. On the preferential release of dopamine in the nucleus accumbens by amphetamine: Further evidence obtained by vertically implanted concentric dialysis probes
14. The role of dopamine in drug abuse viewed from the perspective of its role in motivation
15. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
16. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
17. 2 dopamine receptors studied by PET: A comparison to the equilibrium analysis
18. Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil
19. Head movement in normal subjects during simulated PET brain imaging with and without head restraint
20. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons
21. Human dopamine receptors subtypes-in vitro binding analysis using [3H]SCH 23390 and [3H]raclopride
22. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride
23. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding
24. A simple synthesis of [11C]methyl triflate
25. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex in human brain
26. 125I]epidipride
27. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
28. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging
29. Absolute PET quantification with correction for partial volume effects within cerebral structures
30. D2-family receptor distribution in human postmortem tissue: An autoradiographic study
31. 11C]raclopride studies
32. Simplified reference tissue model for PET receptor studies
33. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters
34. 123I]iodobenzofuran and single photon emission computerized tomography
35. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
36. Ondelettes with exponential localization
37. The D-3 dopamine receptor: Neurobiology and potential clinical relevance
38. Anatomy of the dopaminergic neuron systems in the rat brain
39. Distribution volume ratios without blood sampling from graphical analysis of PET data
40. The organization of midbrain projection to the ventral striatum in the primate
41. A theory for multi resolution signal decomposition: The wavelet representation
42. Comparison of amphetamine-induced endogenous dopamine release in striatal substructures in humans using PET
43. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol. A dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans
44. Performance characteristics of a head immobilization device for PET imaging
45. Wavelet denoising of PET images: Effect on the accuracy of the AIR algorithm
46. Correction of PET data for partial volume effects in human cerebral cortex by MR Imaging
47. Comparative evaluation of MR-based partial-volume correction schemes for PET
48. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
49. From motivation to action: Functional interface between the limbic system and the motor system
50. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects
51. Correction for partial volume effects in PET: Principle and validation
52. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects
53. Partial volume effect correction: Methodological considerations
54. Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics
55. Measuring PET scanner sensitivity: Relating count rates to image signal to noise ratios using noise equivalent counts
56. Reproducibility of repeated measures of carbon-11 raclopride binding in the human brain
57. 11C]raclopride in the human brain
58. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
59. Measurement of dopamine release with continuous infusion of [11C]raclopride: Optimization and signal-to-noise considerations
60. A single scatter simulation technique for scatter correction in 3D PET
61. Performance evaluation of the positron scanner ECAT EXACT
62. Rapid automated algorithm for aligning and reslicing PET images
63. MRI-PET registration with automated algorithm
64. Automated image registration: I. General methods and intrasubject, intramodality validation